why Veru Inc. [VERU] is a Good Choice for Investors After New Price Target of $34.00


Veru Inc. [NASDAQ: VERU] gained 10.24% on the last trading session, reaching $17.23 price per share at the time. The company report on July 12, 2022 that Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced the granting of inducement awards to three new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the award was made as a material inducement to the three employees’ entry into employment with the Company.

In connection with the commencement of employment, two employees received stock options on July 07, 2022, and one employee received stock options on July 11, 2022, to purchase an aggregate 94,450 shares of Veru common stock under the Company’s recently adopted 2022 Employment Inducement Equity Incentive Plan. The stock awards vest in three equal annual installments beginning on the first anniversary of the grant date, subject to each employees’ continued service with the Company through the applicable vesting date.

Veru Inc. represents 80.05 million in outstanding shares, while the company has a total market value of $1.25 billion with the latest information. VERU stock price has been found in the range of $15.40 to $17.765.

If compared to the average trading volume of 14.93M shares, VERU reached a trading volume of 14911639 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Veru Inc. [VERU]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VERU shares is $34.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VERU stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Jefferies have made an estimate for Veru Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 13, 2021. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price from $12 to $17. The new note on the price target was released on February 09, 2021, representing the official price target for Veru Inc. stock. Previously, the target price had yet another raise from $4.50 to $6, while H.C. Wainwright kept a Buy rating on VERU stock.

The Average True Range (ATR) for Veru Inc. is set at 1.51, with the Price to Sales ratio for VERU stock in the period of the last 12 months amounting to 20.69. The Price to Book ratio for the last quarter was 10.14, with the Price to Cash per share for the same quarter was set at 1.54.

Trading performance analysis for VERU stock

Veru Inc. [VERU] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 29.35. With this latest performance, VERU shares gained by 39.63% in over the last four-week period, additionally plugging by 182.92% over the last 6 months – not to mention a rise of 147.56% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VERU stock in for the last two-week period is set at 69.14, with the RSI for the last a single of trading hit 76.27, and the three-weeks RSI is set at 64.67 for Veru Inc. [VERU]. The present Moving Average for the last 50 days of trading for this stock 12.77, while it was recorded at 15.82 for the last single week of trading, and 8.52 for the last 200 days.

Veru Inc. [VERU]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Veru Inc. [VERU] shares currently have an operating margin of -8.88 and a Gross Margin at +78.05. Veru Inc.’s Net Margin is presently recorded at +12.07.

Return on Equity for this stock inclined to 8.11, with Return on Assets sitting at 6.44.

Veru Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.30 and a Current Ratio set at 6.60.

An analysis of insider ownership at Veru Inc. [VERU]

There are presently around $392 million, or 44.00% of VERU stock, in the hands of institutional investors. The top three institutional holders of VERU stocks are: PERCEPTIVE ADVISORS LLC with ownership of 4,361,998, which is approximately -2.007% of the company’s market cap and around 19.49% of the total institutional ownership; BLACKROCK INC., holding 4,113,505 shares of the stock with an approximate value of $70.88 million in VERU stocks shares; and VANGUARD GROUP INC, currently with $54.26 million in VERU stock with ownership of nearly 3.958% of the company’s market capitalization.

Positions in Veru Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 50 institutional holders increased their position in Veru Inc. [NASDAQ:VERU] by around 1,530,413 shares. Additionally, 63 investors decreased positions by around 2,110,754 shares, while 14 investors held positions by with 19,128,424 shares. The mentioned changes placed institutional holdings at 22,769,591 shares, according to the latest SEC report filing. VERU stock had 13 new institutional investments in for a total of 348,239 shares, while 25 institutional investors sold positions of 553,105 shares during the same period.